Immunotherapy for neuroblastoma: turning promise into reality.
Neuroblastoma is one of the commonest and most aggressive paediatric malignancies. The majority of children present with metastatic disease for which long-term survival remains poor despite intensive multi-modal therapies. Toxicity from current treatment regimes is already significant, and there is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2009-07-09.
|
| Subjects: | |
| Online Access: | Get fulltext |